Literature DB >> 24143952

Giant cell arteritis presenting with uveitis.

Stephanie N Slemp1, Sarah E Martin, Richard A Burgett, Eyas M Hattab.   

Abstract

Giant cell arteritis, also known as temporal arteritis, is the most common primary vasculitis affecting the nervous system. Early recognition of this treatable condition is essential to avoid potentially devastating complications. Giant cell arteritis occurs in adults older than 50 years and affects large and medium-sized arteries, especially the external and internal carotid arteries and their branches. Severe inflammation of the vessel wall may result in obstruction of the lumen and end-organ ischemia. Typical giant cell arteritis symptoms include headache, scalp tenderness, jaw claudication, and polymyalgia rheumatica. Ischemia induced by the arteritis can lead to blindness. Herein, we describe a rare case of giant cell arteritis in a patient who initially presented with uveitis, thus eluding timely diagnosis and prompt therapy.

Entities:  

Keywords:  Giant cell arteritis; temporal arteritis; uveitis

Mesh:

Substances:

Year:  2013        PMID: 24143952     DOI: 10.3109/09273948.2013.849351

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  3 in total

Review 1.  Giant cell arteritis: ophthalmic manifestations of a systemic disease.

Authors:  Elisabeth De Smit; Eoin O'Sullivan; David A Mackey; Alex W Hewitt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-05       Impact factor: 3.117

2.  MRI displays involvement of the temporalis muscle and the deep temporal artery in patients with giant cell arteritis.

Authors:  Simon Veldhoen; Thorsten Klink; Julia Geiger; Peter Vaith; Cornelia Glaser; Thomas Ness; Dirk Duwendag; Marcus Both; Thorsten A Bley
Journal:  Eur Radiol       Date:  2014-06-04       Impact factor: 5.315

Review 3.  Ocular inflammatory disease in patients with polymyalgia rheumatica: A case series and review of the literature.

Authors:  Sepideh Faez; Ann-Marie Lobo; Sebastian H Unizony; John H Stone; George N Papaliodis; Lucia Sobrin
Journal:  Clin Rheumatol       Date:  2014-04-03       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.